Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Formulary Cost-Sharing In Patients' Rights Bill Likely Awaits Conference Cmte

Executive Summary

Cost-sharing for non-formulary drugs in the patients' bill of rights is likely to be finalized in conference committee.

You may also be interested in...



Medicare Rx Debate Will Define Formularies; Pfizer Takes Aim At Tiers

Pfizer is renewing its push for a federal definition of formularies that ensures that no patient can be forced to pay a higher copay for a prescription drug deemed to be medically necessary by a physician

Medicare Rx Debate Will Define Formularies; Pfizer Takes Aim At Tiers

Pfizer is renewing its push for a federal definition of formularies that ensures that no patient can be forced to pay a higher copay for a prescription drug deemed to be medically necessary by a physician

Conn. Formulary Suit Dismissed: State Lacks Standing, Appeals Court Says

The state of Connecticut lacks the appropriate legal standing to challenge a managed care formulary under ERISA, a March 27 appeals court decision states

Related Content

UsernamePublicRestriction

Register

PS038143

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel